Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Ozon Pharmaceuticals began collecting applications for participation in the IPO

10/11/24 OZPH

APRI developer Sergey Shal has been appointed head of the company

10/11/24 APRI

Positive Technologies enters the data protection market

10/10/24 POSI

Fesco launched a regular container train from China to Russia

10/10/24 FESH

Henderson's revenues rose 13% in September

10/10/24 HNFG

Yandex launched a mobile application Alice

10/10/24 YDEX

Investment in the development of the Kolmozerskoye field will amount to ₽91 billion

10/10/24 GMKN

VTB does not plan to buy back its shares from non-residents

10/10/24 VTBR

T-Bank acquired 6.15% of Eurotrans

10/10/24 EUTR

M.Video-Eldorado for 9 months opened 68 new stores

10/10/24 MVID